A recent report has claimed that an anti-cholesterol drug, TriLipix doesn’t work better than a generic medicine to protect against heart attacks or strokes. TriLipix is manufactured by Abbott Laboratories, which may face an adverse impact of the report. The report was prepared by the advisory panel of The U. S. Food and drug Administration.

Forty-three lots of MediSense Optium Blood Glucose Test Strips by Abbott are being recalled as they have been found to provide inaccurate readings. The recall of this blood monitoring device is being overseen by the Health Sciences Authority.

Abbott Laboratories is reported to have announced a voluntary recall on Wednesday for its glucose test strips that are used as a tool for monitoring diabetics' blood sugar. It is claimed that the recall of over 359 million glucose test strips because the strips gave inaccurate readings to the patients.

On Wednesday, Abbott Laboratories Inc. announced that it is planning to recall around 5 million units of infant formula after beetles and larvae were found in the product at a plant in Michigan.

Since the news of the recall of Similac baby formula has spread, many parents are worried and trying to confirm that their children haven't consumed the contaminated product.

Abbott Laboratories have decided to withdraw Similac brand powdered infant formulas from the United States, Puerto Rico, Guam, and a few other Caribbean nations.

A federal advisory panel was questioned in lieu of banning the recently developed weight-loss drug made by Abbott Laboratories, which has possible cause of heart attack in recent future.

According to researchers Sunday, Abbott Laboratories experimental, minimally invasive heart valve device meant for repairing the commonest kind of heart valve problems, has met the primary goals of a pivotal study which found it to be safer and almost as effective as open heart surgery.
 

European regulatory authorities on Thursday said an Abbott Laboratories (ABT) diet pill should be banned from sale in the market, issuing tougher warnings for the drug because the drug poses high risks of stroke and heart attack.

The warning was conveyed after a study of 10,000 patients suggested it put them at a higher risk for heart disease.

American drug producer Abbott Laboratories is reportedly close to an agreement to buy Belgium drugs conglomerate Solvay SA's pharmaceutical unit in a deal worth around $7 billion.

Under the deal, apart from acquiring exclusive rights to Trilipix, which is a new cholesterol cure, Abbott will obtain exclusive possession rights of the TriCor cholesterol pill.

Boston Scientific's older Taxus element was outperformed by Abbott Laboratories' Xience V heart on a measure of effectiveness and safety but could not manage to display an important advantage in diabetic patients.

Stents are little wire-mesh scaffolds which are used to open blocked or narrowed arteries. Medicines that coat the stents are helpful in preventing re-clogging.